Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment.

ABSTRACT:

SUBMITTER: Gisslinger H 

PROVIDER: S-EPMC10539163 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature